Convatec Group (LSE:CTEC) FFO


LSE:CTEC Convatec Group PLC LSE:CTEC
77 GF Score
Price £2.12
GF Value £2.55
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Convatec Group FFO?

FFO (Funds from operations) only applies to REITs.

LSE:CTEC
77GF Score
Convatec Group PLC LSE:CTEC
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Convatec Group (LSE:CTEC) Overvalued in 2026?

Based on GuruFocus' analysis, Convatec Group stock appears to be undervalued. The current stock price of £2.12 is trading 16.9% below its estimated GF Value™ of £2.55. GuruFocus considers Convatec Group to be Modestly Undervalued.

Key valuation signals for LSE:CTEC:

  • FFO:
  • GF Value™: £2.55 vs. price of £2.12 (16.9% below fair value)
  • GF Score™: 77/100 with 4 warning signs

No single metric tells the full story. See the LSE:CTEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Convatec Group Business Description

Address 20 Eastbourne Terrace, 7th Floor, London, GBR, W2 6LG
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 32% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (22% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.
77GF Score

Get the complete analysis for LSE:CTEC

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£2.12
Price
£2.55
GF Value